Drug research

rVA576

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as nomacopan

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
rVA576 (Coversin) Long Term Safety and Efficacy Surveillance StudyNCT03829449	AKARI Therapeutics	Phase 3	Terminated	2020-08-29Actual
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576NCT03588026	AKARI Therapeutics	Phase 3	Completed	2020-09-03Actual
rVA576 in Adult Mild to Moderate Bullous Pemphigoid SubjectsNCT04035733	AKARI Therapeutics	Phase 2	Completed	2020-03-12Actual

AKARI TherapeuticsTerminatedPrimary completion: 2020-08-29 · Actual

Trial details

AKARI TherapeuticsCompletedPrimary completion: 2020-09-03 · Actual

Trial details

AKARI TherapeuticsCompletedPrimary completion: 2020-03-12 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.